Minuscule particles with the ability to cross hard-to-penetrate barriers can be loaded with drug treatments to target intractable diseases.

Researchers showed that "exosomes" from pig semen may be used in a potential new treatment for retinoblastoma.

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

The human eye is like an immunological fortress, with its ability to exclude unwanted intruders a boon when preventing ...

Researchers at the National University of Singapore have engineered a common gut bacterium to carry a chemotherapy prodrug ...

Announcing a new publication for Acta Materia Medica journal. Ribonucleic acid for injection II is a clinical adjuvant cancer therapy treatment based on immunotherapy, which exerts its effects by ...

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

Cancer puts up a formidable defense. As cancer cells grow, they pump out molecules that weaken and confuse attacking immune cells, lowering their ability to fight off tumors. A team from the ...